Ani Pharmaceuticals (ANIP) Return on Equity (2021 - 2023)

Ani Pharmaceuticals (ANIP) has 3 years of Return on Equity data on file, last reported at 0.0% in Q1 2023.

• For the quarter ending Q1 2023, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2023 stood at 0.0% (changed 0.0% YoY), and the FY2022 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Equity improved to 0.0% in Q1 2023, from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2023 to a low of 0.0% in Q3 2022.
• A 3-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Equity.
• Peak annual rise in Return on Equity reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Tracing ANIP's Return on Equity over 3 years: stood at 0.0% in 2021, then rose by 8 bps to 0.0% in 2022, then jumped by 45 bps to 0.0% in 2023.
• Business Quant data shows ANIP's Return on Equity at 0.0% in Q1 2023, 0.0% in Q4 2022, and 0.0% in Q3 2022.